These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21801111)

  • 1. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A.
    He J; Wang T; Dong J
    J Dermatolog Treat; 2012 Dec; 23(6):461-4. PubMed ID: 21801111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of botulinum toxin A injection for the treatment of secondary axillary bromhidrosis.
    He J; Wang T; Dong J
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1641-1645. PubMed ID: 28754234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Safety and Efficacy of Botulinum Toxin A Treatment in Adolescent Patients with Axillary Bromhidrosis.
    Wang T; Dong J; He J
    Aesthetic Plast Surg; 2018 Apr; 42(2):560-564. PubMed ID: 29344685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low initial botulinum toxin A treatment response does not predict poor long-term outcomes in patients with axillary bromhidrosis.
    He J; Wang T; Dong J
    J Dermatolog Treat; 2018 Feb; 29(1):102-104. PubMed ID: 28489483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
    Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local injection of botulinum toxin A: an alternative therapy for axillary osmidrosis.
    Xie A; Nie L; Tan Q
    J Dermatol; 2014 Feb; 41(2):153-6. PubMed ID: 24386960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
    Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
    Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
    Heckmann M; Teichmann B; Pause BM; Plewig G
    Arch Dermatol; 2003 Jan; 139(1):57-9. PubMed ID: 12533165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial.
    Montaser-Kouhsari L; Zartab H; Fanian F; Noorian N; Sadr B; Nassiri-Kashani M; Firooz A
    J Dermatolog Treat; 2014 Aug; 25(4):337-41. PubMed ID: 23106157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders.
    Rajanala S; Salame N; Dover JS
    Dermatol Surg; 2024 Sep; 50(9S):S103-S111. PubMed ID: 39196843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.